Sign In
Home
News
Politics
White House
Senate
House
Campaigns
Policy
2026 Election
Opinion
Editorials
Op-Eds
In Focus
Restoring America
Magazine
Watch
Sponsored
Powering Progress
ASAE – Association Leadership
Examining Tax Reform
Fix TSCA
National Parks
Inside the Corn Belt
TWS Archive
Search
Washington Examiner
Subscribe
Search
Washington Examiner
Sign in
Subscribe
News
Politics
Trump Administration
White House
Senate
House
Campaigns
Business
World
Investigations
Justice
Supreme Court
Crime
Entertainment
Washington Secrets
Policy
Defense
National Security
Energy and Environment
Education
Immigration
Finance and Economy
Healthcare
Foreign Policy
Tech
Infrastructure
Space
2026 Election
Trump Administration
IN FOCUS
Commentary
Columnists
Editorials
Think Tanks
Beltway Confidential
Op-Eds
Restoring America
Patriotism and Unity
Faith, Freedom, and Self-Reliance
Courage, Strength, and Optimism
Equality, Not Elitism
Community and Family
Fairness and Justice
Mission
Watch
Magazine
Magazine
Quarterly Briefing
Archives
Games
Sponsored
Powering Progress
ASAE – Association Leadership
National Parks
Examining Tax Reform
Fix TSCA
Inside the Corn Belt
Newsletters
More
Home
›
Authors
›
Posts by ken-armstrong
ken-armstrong
Read the latest stories and analysis from ken-armstrong.
Healthcare
Pharma’s windfall: The mining of rare diseases
ken-armstrong
·
November 11, 2013 5:00 am
1
Page 1 of 1
